Sarcomes des Tissus Mous Traitement - epathologies

More documents

Recommendations

Info

Treatment of GIST with Glevec • 80% of immediate non-progression • about 10% of re-progression during the first year • minimal efficient dose = 400mg (cost = 2000 euros/month) • minor secondary effects • rare major secondary effects • length of treatment ? • Problem of progression ? • Adjuvant teratment ?
• Metastases ? Soft tissue sarcomas Therapeutic decision • Possible conservative treatment ? • Embryonal histologic type ?
Page 1 and 2: Prognosis of soft tissue sarcomas
Page 3 and 4: Soft tissue sarcomas Treatment •
Page 5: Soft tissue sarcomas Locoregional e
Page 10: Soft tissue sarcomas Locoregional e
Page 13 and 14: Soft tissue sarcomas Lymph node ext
Page 15 and 16: Soft tissue sarcomasMétastases : l
Page 17: Soft tissue sarcomas Pre-treatment
Page 20 and 21: Soft tissue sarcomas • Excision
Page 22 and 23: WIDE RESECTION
Page 26 and 27: Soft tissue sarcomas Radiotherapy
Page 28 and 29: Soft tissue sarcomas Chemotheray
Page 30 and 31: Targetd molecular therapy • Anti-
Page 34 and 35: M+ CT ± Ch ± RT Treatment of soft
Page 36: Soft tissue sarcomas Post-treatment

Sarcomes des Tissus Mous Traitement - epathologies

Create successful ePaper yourself

Delete template?

Save as template?